Validation of Ultrasound "Angle of Progression" Measurement to Decrease the Cesarean Rate

NCT ID: NCT05779735

Last Updated: 2024-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

182 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-13

Study Completion Date

2025-10-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Ultrasound during labor and measurement of Angle of progression showed extensive prospective and retrospective publications since 2010. The investigators performed between 2013 and 2016 the only one multicenter, randomized controlled Trial comparing digital exam to angle of progression after a prolonged 2-hour second stage of labor with uncertain fetal head. The investigators consider a cut off of 120° to accepted vaginal birth among cephalic occiput anterior position This randomised PILOT study showed that measurement of Angle of progression in addition to digital exam reduced caesarean delivery from 41% to12% ( n= 33, p=0,06). doi: 10.1016/j.ajog.2022.04.018.

The objective of this new study is therefore to validate the results of this PILOT study in a more powerful multicenter randomized trial (DELIVERY).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Prolonged Second Stage of Labor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1 : control

The mode of delivery will be determined by clinical examens (digital examination)

Group Type NO_INTERVENTION

No interventions assigned to this group

Group 2 : Transperineal ultrasound measurements of AOP

The mode of delivery will be determined by clinical examens (digital examination) and ultrasound measurement of the AOP :

* vaginal delivery is encouraged if AOP measurement is \>120°
* cesarean delivery is encouraged if AOP measurement is \<= 120°

Group Type EXPERIMENTAL

Transperineal ultrasound measurements of AOP

Intervention Type DIAGNOSTIC_TEST

The angle of progression (AOP) defined as the angle between the pubic bone axis and the leading part of the fetal head

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Transperineal ultrasound measurements of AOP

The angle of progression (AOP) defined as the angle between the pubic bone axis and the leading part of the fetal head

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Nulliparous or multiparous women with no history of vaginal delivery,
* \> or = 37 weeks amenorrhoea
* Cephalic presentation in anterior position (occipito-pubic position, left anterior occipito-iliac and right anterior occipito-iliac ) confirmed by ultrasound
* uncertain fetal head engagement on digital examination or midline fetal presentation in prolonged second stage of labor (at least 2 hours),

Exclusion Criteria

* Multiparous women who were previous vaginal deliveries,
* Presentation other than cephalic,
* Twin pregnancies,
* Posterior or transverse position
* Transperineal ultrasound for head-perineum distance measurement
* Fetal heart rate abnormalities requiring rapid delivery,
* Contraindication to vaginal delivery whether maternal or fetal
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital St. Joseph, Marseille, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Baptiste Haumonte

Role: PRINCIPAL_INVESTIGATOR

Hopital Saint Joseph Marseille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Lille - Hôpital Jeanne de Flandre

Lille, , France

Site Status RECRUITING

APHM Hôpital Conception

Marseille, , France

Site Status RECRUITING

Hopital Saint Joseph

Marseille, , France

Site Status RECRUITING

APHM Hôpital Nord

Marseille, , France

Site Status RECRUITING

Hôpital Armand Trousseau AP-HP

Paris, , France

Site Status RECRUITING

CHIC Poissy

Poissy, , France

Site Status RECRUITING

CHITS Hôpital Sainte Musse

Toulon, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rahamia Ahamada

Role: CONTACT

0033488731071

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Rahamia AHAMADA

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2022-A01978-35 DELIVERY

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.